C ardiac arrest survivors often have severe neurologic sequelae that contribute to their early mortality and poor functional recovery. Induced postresuscitative hypothermia was first reported almost 40 yrs ago as a technique for improving functional outcomes after cardiac arrest (1, 2) . The conceptual appeal of such therapeutic hypothermia stemmed primarily from the notion that decreases in core temperature lead to decreased cellular metabolic demand. Cerebral metabolic demand decreases by approximately 6% per degree Celsius (3) . Despite this, postresuscitative hypothermia was largely abandoned as a difficult and resource-intensive technique with uncertain clinical benefits.
However, the clinical induction of hypothermia has found widespread acceptance in the perioperative setting during cardiac bypass and certain neurosurgical procedures. In the surgical setting, unlike cardiac arrest, hypothermia is induced before the ischemic insult occurs. Indeed, in the relatively controlled environment of the operating suite, hypothermia induction has been a viable therapeutic option that is protective against conditions of altered blood flow. In addition, hypothermia has also been applied to the treatment of malignant hyperthermia, traumatic brain injury, and acute myocardial infarction (4 -7) .
Two recent multiple-center, prospective studies of comatose survivors of outof-hospital cardiac arrest demonstrated improved neurologic outcome at hospital discharge (8) and improved neurologic outcome and mortality rate at 6 months (9) in patients receiving 12-24 hrs of hypothermia (32-34°C) after return of spontaneous circulation. Based on the strength of these findings, the International Liaison Committee on Resuscitation recommended the induction of therapeutic hypothermia for 12-24 hrs in selected comatose survivors after out-ofhospital cardiac arrest with initial ventricular fibrillation (10) . The International Liaison Committee on Resuscitation advisory statement calls for the development of hypothermia-induction techniques that are rapid, convenient, and minimally invasive.
Hypothermia Induction Methodologies: Surface and Internal Cooling
Each method for inducing hypothermia represents a different compromise among invasiveness, cooling rate, temperature control, and ease of use. Minimally invasive surface cooling techniques such as ice packs, forced-air cooling mattresses and blankets, and cooling caps have been used in clinical studies of patients with cardiac arrest (8, 9, 11, 12) . In the Hypothermia After Cardiac Arrest study, the median time from return of spontaneous circulation to target core temperature (32-34°C) was 8 hrs (interquartile range, 4 -16 hrs), with typical cooling rates of Ͻ1°C/hr (9). Some surface methods used in these studies require minimal equipment (e.g., ice packs) and can be initiated by paramedics. Others, such as cooling mattresses/blankets, require specialized equipment.
Internal cooling techniques such as endovascular cooling catheters have been developed to address the induction, maintenance, and rewarming phases of hypothermia. Such catheters have demonstrated rapid cooling rates in humansized swine (4.5°C/hr) and nonhuman primates (6.3°C/hr) (13, 14) . Recently, the Cool-MI study utilized endovascular cooling catheters for inducing hypothermia in awake, but sedated, patients in the setting of acute ST-segment elevation myocardial infarction (4) . Although more invasive, this approach provides faster cooling rates and more precise temperature control than surface cooling. Other internal cooling techniques reported include the use of hemodialysis (15) . Internal cooling techniques provide faster cooling; however, some of this advantage is lost because additional time is required for the set-up and placement of catheters and support equipment before cooling is initiated.
Recent studies have demonstrated that an intravenous bolus of chilled single-phase crystalloid fluid can quickly induce hypothermic core temperatures (16 -19) . Infusion of a large-volume bolus (40 mL/kg) of chilled saline via a femoral catheter produced an average 2.5°C decrease in core temperature within approximately 30 mins (17) . One study of comatose out-of-hospital cardiac arrest survivors demonstrated an average 1.7°C decrease in bladder temperature after a bolus (30 mL/kg) of chilled (4°C) lactated Ringer's (given via peripheral or via central catheter). In addition, the group demonstrated a significant increase in mean arterial pressure. Despite the large bolus volume, none of the postarrest patients developed clinical or radiographic evidence of pulmonary edema (16) .
The cooling rates achieved by intravenous chilled saline seem quite rapid, yet the large bolus volumes required to reach hypothermic temperatures remain a potential concern given the variation in cardiopulmonary dysfunction that may occur after return of spontaneous circulation. In addition to cardiac arrest, other resuscitation settings may require high cooling potential with limited fluid volumes. For example, recent strategies proposed for the treatment of hemorrhagic shock or traumatic brain injury include the use of hypertonic saline or the induction of mild hypothermia. Both strategies may attenuate inflammation associated with global ischemia/ reperfusion (7, 20) . However, higher sodium loads and concerns of diluting clotting factors or increasing edema limit the volume of saline that can be given.
Development of a Saline Slurry for Intravenous Application
We tested a microparticulate slurry (MPS) coolant originally developed by Argonne National Laboratory for industrial cooling applications. MPS, a two-phase fluid composed of smooth globular ice particles of Ͻ100 m in diameter suspended in a liquid carrier medium (Fig.  1) , has an inherent thermodynamic advantage over liquid saline, stemming from the energy required to melt ice in solution. For ice solutions, this so-called latent heat of fusion is approximately 80 cal/g solution. Accordingly, it requires 74 kcal of energy to melt and warm a 1000-mL sample of slurry composed of a 1:1 mixture of ice and saline from 0 to 34°C. By contrast, warming a similar sample of saline requires only 34 kcal.
A proprietary procedure for chemically and thermally smoothing individual ice particles is used to create a highly flowable MPS that can pass through small-diameter tubing without plugging (21) . By contrast, ordinary ice-liquid suspensions (e.g., slush beverages) are composed of dendritic ice crystals that do not flow at high ice-particle loading values without plugging. The prototype MPS yields saline with a salt concentration of 1.5% by weight when fully melted. Although this MPS is necessarily hypertonic, future design improvements will likely yield solutions with decreased salt concentrations.
METHOD
We hypothesized that an intravenous bolus of MPS would induce hypothermia (32-34°C) more quickly than an equal bolus of chilled saline. We studied 11 farm swine, Sus scrofa domestica, using a protocol approved by the Institutional Animal Care and Use Committee. The swine were anesthetized with an intramuscular cocktail of ketamine, xylazine, tiletamine, and zolazepam (each at 2.2 mg/kg), followed by 1-2% isoflurane inhalant for maintenance of an appropriate depth of anesthesia during mechanical ventilation. A modified 9-Fr catheter was then placed in the right femoral vein for delivering the cooling solutions. Animals underwent bilateral temporal craniotomies for placement of thermocouples at a depth of 1.25 cm for recording cortical temperatures. Thermocouple probes, embedded in a thermoconductive paste, were inserted into the ear canal to the tympanic membrane for recording bilateral tympanic membrane temperatures. Rectal and inferior vena cava (IVC) temperatures were also recorded. Temperature data were acquired at 1-min intervals.
Three groups of animals were studied: saline infusion, MPS infusion, and anesthetized controls. For the saline group, a bolus (50 mL/kg target dose) of chilled (0 -1°C) saline (1.5% NaCl by weight) was pumped through insulated tubing using a roller pump at 120 mL/min. During administration, temperatures were recorded at 1-min intervals for 60 mins after the start of the infusion. The animals were then killed. The MPS group received the same volume (50 mL/kg) of the MPS (equilibrium temperature of Ϫ1 to 0°C) initially, composed of a 1:1 mixture of distilled ice and H 2 O plus 1.5% non-iodinated NaCl by weight. Although the initial ice loading of this mixture is 50%, a substantial amount of melting occurs during slurry processing to yield a delivered value of 15-20% ice by weight. Control data were obtained from animals utilizing the same anesthesia protocol and instrumentation without cooling.
RESULTS
The experimental group characteristics are detailed in Table 1 . The weights of the saline and MPS animals were statistically indistinguishable. The average weight of the control group was statistically less than the saline group. Given their smaller thermal mass, the control group would be expected to display increased cooling rates after induction of general anesthesia, thus overestimating the effect of sedation alone on cooling rate (22) . The delivered weight-based dosages of intravenous coolants, initial cortical temperatures, infusion time periods, mean arterial pressure, and heart rate were statistically indistinguishable in the saline and MPS groups. All experiments were performed in the same climate-controlled animal surgical suite set for 21-23°C.
With cooling, brain cortex temperatures in the saline and MPS groups decreased rapidly to their minima during the average infusion period of approximately 18 mins (Fig. 1) . Minimum cortical temperatures for the MPS group were significantly lower than those of the chilled saline group (Fig. 2, Table 2 ). The cortex in each of the MPS swine reached temperatures of Յ34°C within an average time period of 7.0 (range, 3-10) mins, with an average absolute change in temperature of 5.3 Ϯ 0.7°C, when the 20% ice-loaded MPS was delivered at a rate of 120 mL/min. The saline pigs achieved a 3°C temperature decrease after an average of 16.3 (range, 13-19) mins when near-0°C chilled saline was delivered at 120 mL/min; however, due to average initial core temperatures of Ͼ37°C, none crossed into the target range (32-34°C).
Average initial cooling rates using an infusion rate of 120 mL/min were estimated by averaging linear least-squares Table  2) . Because the control pigs did not achieve minimum temperatures, their initial rates were calculated by choosing the temperature at the end of the average infusion period. At the same rate of infusion, the average initial cooling rate for the MPS group was approximately 50% faster than the saline group. After the infusion period, cortical temperatures partially rebounded to temperatures that were still significantly below the minimum cortical temperature of the control group.
Average rectal, tympanic membrane, cortical, and central venous temperatures for the saline group are presented in Figure 3 . As expected, the venous temperature (from the thermocouple placed in the IVC) displayed the largest reduction in temperature during the infusion period. Like the cortical temperatures, the IVC and tympanic membrane temperatures reached minima followed by partial rebounds after the cessation of infusion. By contrast, the rectal temperature did not reach a minimum and continued to decrease after infusion (although at a slower rate). After the infusion, the temperatures equilibrated with each other after approximately 40 mins.
MPS induced a more profound instantaneous decrease in IVC temperature before dramatically rebounding to equilibrate with the cortical and tympanic membrane temperatures (Fig. 4) . As noted for the cortical temperatures above, the rectal, tympanic membrane, and IVC temperatures did not continue to drop after rebound. Average tympanic membrane temperatures followed cooling trajectories that were qualitatively similar to cortical temperatures, reaching statistically equivalent minima (p Ͼ .90 for paired t-test) with a 2-to 4-min lag between cortical and tympanic thermocouple readings.
Finally, heart rate, mean arterial pressure, and arterial oxygen saturation remained statistically constant throughout the experimental period. In addition, no qualitative changes in the electrocardiogram wave morphologies were noted.
DISCUSSION
The induction of hypothermia has recently been recommended for selected comatose cardiac arrest patients after return of spontaneous circulation (8 -10) .
Given this international advisory statement and its clinical basis, there is a clear need for the development of hypothermia-induction techniques that are rapid, safe, and simple to implement in the emergent setting. Given concerns about fluid volume in resuscitation settings (both for cardiac arrest and hemorrhagic shock), coolants with greater cooling capacities, such as microparticulate ice slurries, may prove useful in this setting.
Characteristics of Intravenous Cooling. Several studies have sought to understand the mechanisms of human thermoregulation through theoretical models and experimental measures (17, (22) (23) (24) (25) .
The simplest models partition the body into core and peripheral compartments. The core compartment, which comprises the highly perfused thoracoabdominal organs and brain, remains at a relatively uniform temperature, despite constant environmental changes. In our study, cortical brain temperatures served as the gold standard for recording core temperature; however, we found good correlation with tympanic membrane temperatures with a 2-to 4-min time lag. As previously observed, we found that rectal temperature was not a good proxy for core temperature (26) . The peripheral compartment, which includes the limbs and skin, is characterized by a labile temperature that compensates for metabolic and environmental changes.
Temperatures in the anesthetized control animals decreased at absolute rates between 0.9 and 1.6°C/hr, which are consistent with temperature changes noted during the first hour after the induction of general anesthesia in humans. This decrease is primarily the result of redistribution of heat from the core to the periphery rather than environmental loss or decreased metabolic rate (27) .
Our data suggest that a large resuscitation volume (50 mL/kg) intravenous bolus of MPS can rapidly induce mild to moderate hypothermia in the core compartment of swine with intact circulation. A bolus of chilled saline did not achieve cortical temperatures of Յ34°C but did produce a significant mean temperature decrease (3.4°C) slightly greater than previous studies utilizing smaller doses (30 -40 mL/kg) of chilled saline in human volunteers and patients with cardiac arrest (16, 17) .
Unlike surface cooling, intravenous coolants induce extremely rapid cortical cooling rates. In the current study, cortical temperature minima were reached within 1 min after completion of the 50 mL/kg bolus. This result suggests that cooling rate is heavily dependent on the rate of infusion such that increased rates of administration will likely yield faster cooling rates.
After the intravenous bolus, core temperatures uniformly displayed a pronounced partial temperature rebound (Fig. 1) . Figure 4 suggests that the observed rebound could be secondary to redistribution of heat from relatively warmer areas such as the rectum, abdominal vessels, or peripheral tissues. Rajek et al. (17) noted a similar rebound effect in their detailed study of intravenous cooling in healthy volunteer subjects. By contrast, they concluded that the rebound was a result of metabolic heat constrained to the core via peripheral vasoconstriction. Despite this partial rebound, the MPS group core temperatures remained at Ͻ34°C.
Changes in Heat Content. As thermodynamic theory predicts, two-phase MPS induces lower core temperatures than chilled saline. To quantify this thermal advantage, we calculated the amount of heat absorbed by the coolants during each trial. The heat content of a liquid coolant increases as it absorbs energy from the body (Appendix, Eq. 1).
Heat content changes for the saline coolant were calculated based on the minimum and rebound temperatures (Table  3) . Heat content changes for the MPS coolant were calculated using an estimated ice load of 20% by weight (Appendix, Eq. 2).
We calculated the energy dissipated by the core compartment by assuming an average tissue-specific heat of 0.83 kcal·kg Ϫ1 ·°C Ϫ1 and an approximate 60/40 partition between the mass of the core and peripheral compartments for humans (27) . Decreases in core compartment heat content for the control, saline, and MPS pig groups were calculated at the minimum and rebound temperatures (Table 3) .
When calculated at the minimum temperature, total increases in coolant heat content are similar to the corresponding decreases in core heat content (Table 3) . However, if we assume that heat absorption is proportionally distributed throughout the peripheral and core compartments, the proportional amount of coolant heating attributable to the core is only 60% of the total value (parenthetical values in Table 3 ). Once adjusted, the core heat loss exceeds the amount proportionally absorbed by the coolant. Such b coolant heat content change attributed to core (in parentheses) was calculated by multiplying the coolant total by the 60% core partition estimate. Data are presented as mean Ϯ SD.
"excess core cooling," previously described in a study of human intravenous cooling, suggests that the coolant is preferentially constrained to the core compartment (17) . Alternatively, this disparity may reflect inaccuracies in our 60/40 compartment partition assumption.
Risks and Benefits of Intravenous Cooling. Clinical studies confirm that humans are difficult to cool. The adult body combats accidental hypothermia by increasing metabolic heat production through shivering and by decreasing environmental losses by thermally isolating the core from the peripheral compartment via peripheral vasoconstriction (17, 22, 28) . These compensatory mechanisms are attenuated during induction of general anesthesia, thus facilitating core cooling with surface methods (27, 29) . However, in the postarrest setting, thermal isolation between the peripheral and core compartments is likely increased by the overall "adrenergic" state of the postarrest patient after administration of vasoactive medications. Our results suggest that intravenous coolants, when administered through a central catheter, may bypass the peripheral compartment completely. Although intravenous coolants may bypass the thermal resistance of the peripheral compartment, this thermal shunting may be attenuated when they are administered through a peripheral vein.
The heat content equation (Appendix, Eq. 2) shows that the cooling capacity of MPS is determined, in part, by the total dosage and ice-loading percentage. We can apply this relationship to the average data from the saline and MPS groups to estimate a range of dosage/ice-load combinations that would induce similar cortical cooling results (Fig. 5) . The top curve, which is based on the MPS data, extrapolates the dosage/ice-load combinations that would produce minimum core temperatures approximately equal to the MPS group. The bottom curve combinations would lead to cooling results similar to the saline group. The region between the curves represents combinations that would lead to minimum temperatures between the MPS and saline group minima. Recall that the saline group did not quite reach the target range (32-34°C), whereas the MPS group produced minimum temperatures of Ͻ32°C. From the top curve of Figure 5 , we can estimate that it would require a bolus of approximately 75 mL/kg of saline (i.e., 0 % ice load) to produce cooling equivalent to 50 mL/kg of 20% ice MPS. Similarly, it would take a bolus of approximately 34 mL/kg of 20% ice MPS to reproduce the saline results 50 mL/kg saline. As illustrated in Figure 5 , when MPS ice loads are increased to Ͼ20%, the bolus volumes required for a given temperature change decrease significantly. With more highly loaded MPS, we expect smaller volumes to achieve the same degree of cooling. Minimizing the total volume of an intravenous coolant bolus might be important for avoiding pulmonary edema after cardiac arrest and hemodilution of clotting factors after hemorrhagic shock. Supporting this goal of reducing coolant volume, our collaborators at Argonne National Laboratory have recently improved MPS ice loading to levels up to 50% by weight. From Figure 5 , we can predict that a 23 mL/kg bolus of 50% ice-load MPS would produce temperature minima similar to those observed in the saline group.
Another important consideration is whether the cooled blood traversing the heart may produce adverse effects. With the MPS group, the IVC reached a minimum temperature of 28.6 Ϯ 1.1°C, which if transmitted to the myocardium, could theoretically induce ventricular fibrillation. Although we saw no adverse effects on hemodynamics or electrocardiogram tracings, this study was not by design powered to detect low-frequency events. A slower infusion rate or smaller bolus would likely attenuate the IVC temperature drop if required. The IVC temperature was almost 5°C lower than the rectal temperature for the MPS group and 2°C in the saline group. This reflects a thermal compartmentalization that could be even more pronounced during the lowflow setting of CPR.
In conclusion, cold intravenous fluids can rapidly induce hypothermia in pigs with intact circulation. A two-phase (liquid plus ice) MPS cools more rapidly and effectively than cold saline at 0°C. Ice slurry could be a significant improvement over other cooling methods when speeds of cooling and low infused volumes are important to the clinician. Further work on methods for the intravenous induction of hypothermia is warranted. 
